References
- Singh D, Upadhyay G, Srivastava RK, et al. Recent advances in pancreatic cancer: biology, treatment, and prevention. Biochim Biophys Acta. 2015;1856:13–27.
- Ganesh T. Improved biochemical strategies for targeted delivery of taxoids. Bioorg Med Chem. 2007;15:3597–3623.
- Huynh L, Leroux JC, Allen C. Enhancement of docetaxel solubility via conjugation of formulation-compatible moieties. Org Biomol Chem. 2009;7:3437–3446.
- Park MH, Keum CG, Song JY, et al. A novel aqueous parenteral formulation of docetaxel using prodrugs. Int J Pharm. 2014;462:1–7.
- Chu C, Xu P, Zhao H, et al. Effect of surface ligand density on cytotoxicity and pharmacokinetic profile of docetaxel loaded liposomes. Asian J Pharmaceut Sci. 2016;11:655–661.
- Xie C, Chang J, Hao XD, et al. Mitochondrial-targeted prodrug cancer therapy using a rhodamine B labeled fluorinated docetaxel. Eur J Pharm Biopharm. 2013;85:541–549.
- Pronk LC, Stoter G, Verweij J. Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effects. Cancer Treat Rev. 1995;21:463–478.
- van Zuylen L, Verweij J, Sparreboom A. Role of formulation vehicles in taxane pharmacology. Invest New Drugs. 2001;19:125–141.
- Tije AJ, Verweij J, Loos WJ, et al. Pharmacological effects of formulation vehicles: implications for cancer chemotherapy. Clin Pharmacokinet. 2003;42:665–685.
- Yadav DK, Pawar H, Wankhade S, et al. Development of novel docetaxel phospholipid nanoparticles for intravenous administration: quality by design approach. AAPS PharmSciTech. 2015;16:855–864.
- Zhang T, Zhou S, Liu Y, et al. Polysialic acid and Pluronic F127 mixed polymeric micelles of docetaxel as new approach for enhanced antitumor efficacy. Drug Dev Ind Pharm. 2017;43:1827–1835.
- Liu F, Feng L, Zhang L, et al. Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel. Int J Pharm. 2013;451:41–49.
- Ren G, Jiang M, Xue P, et al. A unique highly hydrophobic anticancer prodrug self-assembled nanomedicine for cancer therapy. Nanomed: Nanotechnol Biol Med. 2016;12:2273–2282.
- Lu J, Liu C, Wang P, et al. The self-assembling camptothecin-tocopherol prodrug: an effective approach for formulating camptothecin. Biomaterials. 2015;62:176–187.
- Meng F, Hennink WE, Zhong Z. Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials. 2009;30:2180–2198.
- Wu G, Fang Y-Z, Yang S, et al. Glutathione metabolism and its implications for health. J Nutr. 2003;134:489–492.
- Singh M, Harris-Birtill DC, Markar SR, et al. Application of gold nanoparticles for gastrointestinal cancer theranostics: a systematic review. Nanomed: Nanotechnol, Biol, Med. 2015;11:2083–2098.
- Lepeltier E, Bourgaux C, Couvreur P. Nanoprecipitation and the “Ouzo effect”: application to drug delivery devices. Adv Drug Deliv Rev. 2014;71:86–97.
- Beck-Broichsitter M, Nicolas J, Couvreur P. Solvent selection causes remarkable shifts of the “Ouzo region” for poly(lactide-co-glycolide) nanoparticles prepared by nanoprecipitation. Nanoscale. 2015;7:9215–9221.
- Ren G, Liu D, Guo W, et al. Docetaxel prodrug liposomes for tumor therapy: characterization, in vitro and in vivo evaluation. Drug Deliv. 2016;23:1272–1281.
- Han X, Li Z, Sun J, et al. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation. J Control Release. 2015;197:29–40.
- Yang B, Lin J, Chen Y, et al. Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode. Bioorg Med Chem. 2009;17:6311–6317.
- Shen Y, Li Q, Tu J, et al. Synthesis and characterization of low molecular weight hyaluronic acid-based cationic micelles for efficient siRNA delivery. Carbohydrate Polym. 2009;77:95–104.
- Yang C, Hu T, Cao H, et al. Facile construction of chloroquine containing PLGA-based pDNA delivery system for efficient tumor and pancreatitis targeting in vitro and in vivo. Mol Pharm. 2015;12:2167–2179.
- Mo R, Sun Q, Li N, et al. Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids. Biomaterials. 2013;34:2773–2786.